Loading chat...
PA SB95
Bill
Status
7/7/2025
Primary Sponsor
Kristin Phillips-Hill
Click for details
AI Summary
-
Authorizes EMS providers to distribute naloxone dose packages to family members, friends, or others who can assist someone who experienced an opioid overdose, when a Department of Health standing order allows public purchase without prescription
-
Creates a 180-day provisional pharmacy license for pharmacists licensed in other U.S. states or territories, waiving requirements to demonstrate substantially similar licensure standards or competency testing
-
Requires pharmacists to disclose upon request the pharmacy retail price and consumer cost-sharing amount for brand-name drugs and generic equivalents, plus information on applying for health coverage through Pennsylvania's insurance exchange
-
Mandates pharmacies post conspicuous notices informing consumers of their right to request price disclosures; pharmacists are not liable for noncompliance due to technological issues
-
Phases implementation with provisional licensing taking effect immediately, definitions and EMS provisions in 60 days, and price disclosure requirements in one year
Legislative Description
Further providing for definitions, for licensing of pharmacists and for unlawful acts; and providing for price disclosure.
Last Action
Act No. 34 of 2025
7/7/2025